News
Pharma Nobis Completes Acquisition of Fagrons Contract Manufacturing Business and Manufacturing Facility
An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed Pharma Nobis, LLC to acquire Fagron’s US contract manufacturing business. This business unit, operating from a manufacturing facility in...
News
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by Outsourced Pharma and Life Science Leader. Samsung Biologics received a total...
News
Japan Aims For 1 Million Boosters A Day To Fight COVID-19
Fumio Kishida, the Japanese Prime Minister, has recently gone on record to say that he is looking to speed up the country’s COVID-19 booster shots to 1 million a day by the end of February. This figure will be...
News
Judicious Use of The COVID-19 Vaccinations Is A Must Now
It’s been two years since the COVID-19 virus emerged giving way to several new variants that have consistently knocked on the doors. However, to lessen the infection and other related consequences to a significant extent, the vaccination drive has...
News
Long Troubling Symptoms Seen In Kids With COVID Linked MIS-C
According to a recently conducted study in the US, a patch of severe COVID-19 on some children could lead to lasting neurological complications, which is a part of a very rare condition known as multisystem inflammatory syndrome-Children ( MIS-C). These...
News
FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids
A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old will be made available in the US sooner than expected. With the current scenario, it looks like the vaccine...
News
New Phesi global analysis shows breast cancer was the most extensively studied disease area in 2021
Phesi Inc., a data-driven provider of AI-powered clinical development analytics and solutions, has released the results of its global analysis of all clinical trials conducted in 2021. The data show that breast cancer was the most studied disease area,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















